Document is current
Any future updates will be listed below
-
Authors
Robertson, Kevin
Landay, Alan
Miyahara, Sachiko
Vecchio, Alyssa
Masters, Mary Clare
Brown, Todd T.
Taiwo, Babafemi O.
-
Funding
Funding for this research was provided by:
National Institute of Allergy and Infectious Diseases (U01AI068636)
- License Information
-
More Information
Article History
Received: 28 January 2019
Revised: 9 August 2019
Accepted: 16 August 2019
First Online: 29 August 2019
Compliance with ethical standards
:
: A.L. has served on the scientific advisory board for Merck and has provided scientific consultation to GlaxoSmithKline, Bristol-Myers Squibb, and Tobira.T.T. B. as served as a consultant for Bristol-Myers Squibb, GlaxoSmithKline, Merck, AbbVie, Gilead, ViiV, Theratechnologies, and EMD-Serono and has received research funding from Merck and GlaxoSmithKline.B.O.T. has served as a consultant to ViiV, Pfizer, Janssen, GlaxoSmithKline, and Gilead, and received research support to Northwestern University from ViiV and Pfizer.All other authors declared no conflicts of interest.
